P

Pardes Biosciences

49 employees

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

Basic info

Industry

biotechnology research

Sectors

Infectious disease
Biotechnology
Life Science

Date founded

2020

Funding rounds raised

Total raised

$75M

from 8 investors over 8 rounds

P

Pardes Biosciences raised $75M on December 27, 2021

Investors: GMF CAPITAL, Foresite Capital, Frazier Healthcare Partners, Monashee Investment Management LLC, Gilead Sciences, RA Capital Management, L.P. and T. Rowe Price

P

Pardes Biosciences raised $52M on February 3, 2021

Investors: Y Combinator

FAQ